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Available online 20 February 2015Peripheral immune cells are critical to the pathogenesis of neurodegenerative diseases includingmultiple sclero-
sis (MS) (Hendriks et al., 2005; Kasper and Shoemaker, 2010). However, the precise sequence of tissue events
during the early asymptomatic induction phase of experimental autoimmune encephalomyelitis (EAE) patho-
genesis remains poorly deﬁned. Due to the spatial–temporal constrains of traditional methods used to study
this disease,most studies had beenperformed in the spine during peak clinical disease; thus the debate continues
as to whether tissue changes such as vessel disruption represent a cause or a byproduct of EAE pathophysiology
in the cortex. Here, we provide dynamic, high-resolution information on the evolving structural and cellular pro-
cesses within the gray matter of the mouse cortex during the ﬁrst 12 asymptomatic days of EAE induction. We
observed that transient focal vessel disruptions precede microglia activation, followed by inﬁltration of and di-
rected interaction between circulating dendritic cells and T cells. Histamine antagonist minimizes but not
completely ameliorates blood vessel leaks. Histamine H1 receptor blockade prevents early microglia function,
resulting in subsequent reduction in immune cell accumulation, disease incidence and clinical severity.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Although disruption of CNS vessel integrity is a hallmark of MS, it is
not clearwhether such vascular compromise is the initiator or the result
of the neuroinﬂammatory pathophysiology (Lassmann et al., 2007).
Gross vascular compromises have been reported as an early onset indi-
cator in the cerebellum and spine (Floris et al., 2004; Koh et al., 1993;
Muller et al., 2005; Tonra et al., 2001). Current available data, however,
does not adequately describe the nature and dynamics of the vessel
leak. Previous studies on rats have shown: (1) via radiolabeling, that
vessel leaks can be detected in the lower sacral region one day before
clinical disease (Koh et al., 1993) and (2) viaMRI, vessel leaks in the cer-
ebellum and spine are detected by gadolinium on day 11 preceding
macrophage inﬁltration and onset of clinical disease on day 14 (Floris
et al., 2004). These observations are of major breaches in the vessel in-
tegrity, generally in the mm to cm size range. On the other hand, earlyﬁnancial interests.
Room 6528, 2103 Cornell Road,
. This is an open access article undervascular and associated tissue changes in the pre-symptomatic murine
cerebral cortex undergoing EAE pathogenesis are less well deﬁned.
The current dogma dictates that during EAE induction the blood–
CNS barrier is rendered “leaky” by irradiation or pertussis toxin (PTx)
through histamine-mediated effects (Linthicumet al., 1982). As engage-
ment of H1R induces microglia activation (Dong et al., 2014), it is be-
lieved that microglia activation occurs during early EAE induction
phase (Ponomarev et al., 2005). However, pathogenic T cell inﬁltration
does not require microglial expression of the major histocompatibility
antigen class II (MHCII) molecule (Greter et al., 2005), suggesting that
another antigen-presenting cell (APC) subset, the dendritic cells
(DCs), plays a crucial role in re-activating myelin-speciﬁc T cells in the
CNS (Bailey et al., 2007). How circulating DC precursors are attracted
to EAE lesions is not entirely clear.
Myelin-speciﬁc Th17 and Th1 T cells play critical roles in EAE andMS
(Korn et al., 2009). Intravital two-photon microscopy (TPM) studies
have examined the recruitment and behavior of pathogenic T cells in
the mouse brain and spinal cord (Bartholomaus et al., 2009; Flügel
et al., 2007; Herz et al., 2011; McGavern and Kang, 2011; Mues et al.,
2013; Siffrin et al., 2010). These investigators focused their observation
on T cell behavior during peak clinical symptomatic phase. As such,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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transition from the initiation stage to the inﬁltration stage of EAE path-
ogenesis (Lodygin et al., 2013; Odoardi et al., 2012; Sallusto et al., 2012).
However, entry of T cells into the spinal cord in early EAE has been doc-
umented previously (Gordon et al., 2001; Kim et al., 2010; Rothhammer
et al., 2011).
Here, we applied sequential TPM to examine cellular behavior at the
tissue interface between the subarachnoid space (SAS) and cortex dur-
ing the ﬁrst 12 days of asymptomatic induction phase of EAE. We ob-
served transient vessel leaks within the cortical gray matter within the
ﬁrst 3 days of disease induction, which initiated microglia activation,
leading to sequential accumulation of DCs followed by myelin-speciﬁc
T cell inﬁltration. We further showed that inhibiting histamine-
induced microglia activation early in EAE induction could reduce dis-
ease progression. Speciﬁcally, we described early focal, intermittent
and transient disruptions of post-capillary junctional venules following
PTx administration, resulting in dextran uptake by the microglia, and
immune cellular accumulation. Transient vessel leaks initiated an early
parenchymal inﬂammatory response ﬁrst evidenced by microglial up-
take of blood contents, followed by an inﬂux of both CD11b+CD11c+
and CD11b+CD11c− APCs. The increasing numbers of activated CNS-
resident and blood-derived APCs on days 3–6 facilitated the ingress
and retention of activated T cells in a myelin-speciﬁc manner into the
Virchow–Robin Space (VRS) and the parenchyma on days 6–12 before
the clinical onset of disease. In contrast to other intravital imaging stud-
ies involving the spine, we focused our imaging effort on the cortex,
which is relevant to human MS. Interestingly, a distinct pattern of im-
mune cells congregated in patchy tissue niches that were in close prox-
imity to sites of priormicrovessel leaks. Early activation of CNSAPCs and
antigen recognition by T cells in the cortex subsequently affected the
pattern of T cell migration in the cerebellum and spine. In addition, we
show that histamine H1 receptor antagonist curtailed the frequency of
PTx-induced focal vessel leakage, reduced the degree of microglia acti-
vation, diminished subsequent recruitment of circulating immune
cells, and protected mice from EAE incidence and disease severity.
Materials and methods
Mice
2D2 (Bettelli et al., 2003)mice expressing the TCR transgene speciﬁc
forMOG35–55 peptide/I-Ab (Jackson Labs, #006912)were crossedwith
B6.129 (ICR)-Tg actin-beta CFP mice (Jackson Labs, #004218) to derive
mice expressing 2D2-CFP cells for in vivo tracking by TPM. Similarly,
OTII mice expressing the TCR transgene speciﬁc for OVA323–339 pep-
tide/I-Ab (Taconic, #1896) were crossed with C57BL/6-Tg ubiquitin
GFP mice (Jackson Labs, #004353) to derive OTII-GFP cells for in vivo
TPM tracking. C57BL/6J, B6.FVB-Tg CD11c-DTR/GFP mice (Jackson
Labs, #004509) and B6.129P CX3CR1+/GFP mice (Jackson Labs,
#005582) were obtained from Jackson Laboratory. All animals were
housed and handled in accordance with protocols approved by the
CWRU IACUC.
Active EAE induction
EAEwas actively induced in 8–12week old femalemice as previous-
ly described (Stromnes and Goverman, 2006). 3 × 106 naïve splenic
2D2-CFP CD4 T cells, isolated by negative depletion using Dynal beads
(Life Technologies, Grand Island, NY, USA) were injected into recipient
mice. 24 h later, an emulsionwith 200 μgmyelin oligodendrocyte glyco-
protein (MOG) peptide 35–55 (MOG35–55; AnaSpec, San Jose, CA, USA)
with CFA (8 mg/mL H37RA and Incomplete Freund's Adjuvant (IFA);
Difco Laboratories, Detroit, MI, USA) was injected subcutaneously
(s.c.) bilaterally on the lower back of the recipient mouse (Hooke Labo-
ratories, Lawrence, MA, USA). Control mice were injected s.c. bilaterally
with an emulsion consisting of PBS and CFA. 100 ng pertussis toxin wasadministered intraperitoneal (i.p.) on days 0, 1 and 2. Daily clinical as-
sessment ofmicewas performed. Clinical scoreswere assigned as previ-
ously described (Mi et al., 2007; Stromnes and Goverman, 2006).
Blood brain barrier leakiness analysis
To compare the pattern of vessel leakiness induced by different in-
ﬂammatory stimulants, 100 ng LPS (Sigma-Aldrich, St. Louis, MO,
USA), 100 ng PTx or 200 μL of PBS was injected i.p. into C57BL/6 mice
on days 0, 1 and 2. 700 ng of 150 kDa TRITC dextran (Sigma-Aldrich,
St. Louis, MO, USA) vessel dye was injected i.v. on day 1 and day 2. On
day 3, QTracker-655 (Life Technologies, Grand Island, NY, USA) was
injected to highlight the vessels. The mice were sacriﬁced and whole
brain tissues were imaged immediately by TPM.
Priming of antigen-speciﬁc T cells
To determine whether myelin speciﬁc T cells require antigen-
speciﬁc APCs for recruitment to the CNS, EAE was actively induced
using a combination of two antigenic peptides in 8–12 week old female
recipientmice. 3 × 106 naïve 2D2-CFP and 3 × 106 naïve OTII-GFP CD4+
T cells were isolated separately by negative depletion using Dynal beads
and co-injected into naïve recipient mice. 24 h later, an emulsion of
200 μg MOG35–55 only, 10 μg OVA323–339 only, or 200 μg MOG35–
55 and 10 μg OVA323–339 combined (AnaSpec, San Jose, CA, USA)
with CFA (8 mg/mL H37RA and IFA; Difco Laboratories, Detroit, MI,
USA) was injected s.c. bilaterally on the lower back of the recipient
mice. Control mice were injected s.c. bilaterally with an emulsion of
PBS and CFA. 100 ng PTx (List Biological Laboratories, Inc., Campbell,
CA, USA) was administered i.p. on days 0, 1 and 2 to induce EAE.
Flow cytometry analysis
For single-cell APC and T cell characterization, brain tissue was har-
vested on days 0 through 12 of EAE induction. Tissues were dissociated
by collagenase D (1mg/mL) and DNAse (250 units/mL) (Sigma-Aldrich,
St. Louis, MO, USA) to form a single cell suspension after gentle dissoci-
ation with a dounce homogenizer and subjected to a 70%/37%/30%
Percoll (Sigma-Aldrich, St. Louis, MO, USA) gradient (Cardona et al.,
2006). Isolated cells were stained for CD45, CD11c, CD11b, CD4, CD8,
IL-17, IFN-γ and FoxP3. Absolute numbers of cells per brain were deter-
mined by multiplying the number of events on FACS per collection vol-
ume by the total volume of cell samples. Spleen and LN were isolated
from mice at the end of imaging on day 12. Organs were crushed with
the ends of 1 mL syringes through a 40-μm cell strainer into single cell
suspensions and were stained for Vα2 (OTII TCRα chain), Vβ11 (2D2
TCRβ chain), CD4, CD25, CD44, and CD69. Samples were collected and
analyzed using the Accuri ﬂow cytometer (BD Biosciences Co., San
Jose, CA, USA).
Tissue histology analysis
After injection of TRITC vessel dye and completion of intravital imag-
ing, CX3CR1+/GFP mice were sacriﬁced and subjected to transcardial
perfusion with 4% PFA. The brain tissue was harvested and 12-μm
cryo-sections were performed and the samples were then subjected to
confocal microscopy to obtain ﬂuorescent images.
Intravital TMP imaging
Cranial windows were created as previously described (Mostany
and Portera-Cailliau, 2008). The window surgery was performed 4 to
10 days before EAE induction to allow the local surgical site inﬂamma-
tion to subside. On the day of intravital imaging, 150 kDa TRITC dextran
or QTracker 655 was injected i.v. 10 min prior to imaging to highlight
the vasculature. Image acquisition was conducted using Leica SP5
76 D.S. Barkauskas et al. / Experimental Neurology 266 (2015) 74–85microscope system on an upright DM6000 stage (Leica Microsystems,
Inc.) ﬁtted with a 20× (N.A. 1.0) water immersion lens. The SP5 micro-
scope was coupled with a Ti/sapphire laser (16 W Chameleon XR laser,Coherent, Inc.) tuned to 880 nm to illuminate ﬂuorescent elements
within the live tissue. An image volume of 750 × 750× 150 μmwas rou-
tinely collected every 30 s to yield xyzt imaging data set.
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Oral administration at 5mg/kg/daywas used for treatmentwith hy-
droxyzine. For the incidence curve, hydroxyzine was administered via
drinking water at a concentration of 0.1 mM starting from day −1.
Later, for FACS and TPM analyses, 5 mg/kg of hydroxyzinewas adminis-
tered via daily gavage from day−1 to day 12.
Imaging data analysis
Second harmonic generation (SHG) signal produced by high colla-
gen content structureswas used to identify the pial layer and to discrim-
inate the parenchyma from meninges. Relative ﬂuorescent intensity
region of interest (ROI) measurements of dextran leaking into the pa-
renchyma were made using the LAS-AF software (Leica Microsystems
Inc., Buffalo Grove, IL, USA). Timing and duration of vessel leaks were
manually processed. Cellular dextran uptake and CD11c-GFPwere iden-
tiﬁed by ﬂuorescent intensity. Co-localization of TRITC and GFP signals
and volume data were calculated using the Imaris software (BitPlane
Inc., Zurich, Switzerland). T cell motility data was also analyzed using
the Imaris software, which allows cell identiﬁcation, as well as 3D track-
ing over time by producing information on individual positions, time
and track length. T cell interactions with APCs were grouped into
short contacts (b2 min) and prolonged interactions (≥2 min). Individ-
ual T cell migration tracking was further analyzed for track length, ve-
locity, mean ﬂuorescent intensity and cell ﬂux using MATLAB software
(Mathworks Inc., Natick, MA, USA). Cell ﬂux was calculated by deter-
mining the vector between the beginning of the T cell track and the
point at which the T cell came within a 50-μm radius from the center
of an APC cluster. Contact time between APC and T cells, and T cell
movement to and from the blood vessel were analyzed manually by vi-
sual inspection of individual image slices over time using the Imaris
software.
Statistical consideration
Statistical analyses were performed using GraphPad Prism 5 soft-
ware (GraphPad Software Inc., San Diego, CA). For all analyses p b 0.05
was considered signiﬁcant and degrees of freedom (df) are noted.
Results
Transient focal vessel leaks occurred early in EAE
EAE induction efﬁciency and clinical presentation can be variable.
Therefore, to reliably capture rare cellular events by TPMwe introduced
ﬂuorescent-labeled naïve 2D2 cells into recipient animals prior to dis-
ease induction in combination with a low dose of PTx on the ﬁrst
3 days of induction without irradiation (Stromnes and Goverman,
2006). This resulted in 100% disease incidence compared to mice with-
out transferred 2D2 cells (+2D2: n = 6 from 2 experiments;−2D2:
n = 20 from 6 experiments), with hind limb paralysis achieved by
day 21 (Fig. 1a).We focused our intravital observation in the cortex dur-
ing the ﬁrst 12 days of asymptomatic EAE induction (Luo et al., 2008). A
cranial observationwindowwas surgically implanted 4 to 10 days priorFig. 1. PTx administration caused early, transient and focal CNS vessel leaks. (a) Consistent clin
experiments) as compared to non-transferred controls (□; n=20 from6 experiments) prior to
Scale bar = 50 μm. (c) Mean ﬂuorescent intensity (MFI) measurements of the indicated ROIs i
(d) Control mice with cranial window implantation and 7 days of recovery. (e) The duration of
from1 experiment. (f) Frequency of cerebral vessel leakswas quantiﬁedby TPMduring theﬁrst
(g) The duration of individual vessel leaks in (f)wasmeasured dynamically by TPM. Arrows: PTx
vessel dye under the pial surface in the parenchyma (P) as compared to the meninges (M).
perivascular areas of the CNS parenchyma in ﬁxed CX3CR1+/GFP brain tissue, both near the sup
Dash line: Imaging depth achieved by TPM. Scale bar = 100 μm. Data are shown as mean ± Sto induction in order to limit the inﬂammatory changes to structures
and cellular response (Barkauskas et al., 2013; Dorand et al., 2014).
PTx has been shown to disrupt the BBB integrity in EAE (Linthicum
et al., 1982), although the exact location, timing and dynamics of the
vessel breach have not been carefully characterized to date. Using
TPMandﬂuorescent-labeled vessel dye,we directly observed focal tran-
sient leakage of CNS vascular contents hours to days after PTx injections
on days 0 to 2. These transient BBB breaches were visualized as blooms
of dye leaking from the vessels (Fig. 1b; Movie 1). The effect of PTx on
CNS vessel disruption was neither uniform nor permanent, as certain
post-capillary venule junctions were prone to intermittent vessel leaks
while other vessels of similar caliber remained completely intact
(Fig. 1c). Control mice exhibited little to no vessel leaks (n = 4 from 1
experiment), indicating that these leaks were not due to damages asso-
ciated with TPM or prior surgical procedures (Figs. 1d and e). Further-
more, we observed vessel leaks that originated from the vessels
outside of the imaging ﬁeld, arguing against this phenomenon as an ar-
tifact of TPM (Movie 2). When the vessel leaks were serially character-
ized in the same mice through the ﬁrst 12 days of EAE induction, we
observed the highest frequency of vessel leaks during the ﬁrst 3 days
(n = 19 from 8 experiments), coincident with PTx administration
(Fig. 1f). The duration of individual leaks during this early period was
variable, with some lasting ~30 min before resolving (Fig. 1g). While
vessel content quickly dissipated at the pial surface by the bulk CSF
ﬂow in the meningeal space, blood solutes released into the parenchy-
ma took a longer time to clear after resolution of the BBB breach
(Fig. 1h). Evidence of blood persistence can be found deep in the paren-
chyma, as TRITC-labeled dextran was observed on day 3 in ﬁxed brain
tissue (Fig. 1i).
Identity of TRITC+ cells in early EAE
Next, we examined the focal and intermittent nature of the vessel
breach by measuring the location and the dextran uptake activity in
the cortex throughout EAE induction. CX3CR1 is constitutively
expressed by the microglia and a sub-population of macrophages in
the CNS (Kettenmann et al., 2011). To identify the TRITC+ cells, we in-
duced EAE in Cx3cr1+/GFP mice. Five hours after PTx administration on
day 0, the only TRITC+ cells in the meninges and parenchyma were
100% CX3CR1+ cells (Fig. 2a).
Intermittent vessel leaks resulted in localized uptake of blood vessel con-
tents by the microglia
When TRITC-labeled dextran was introduced intravenously on 3
consecutive days during PTx administration, we observed a patchy dis-
tribution of TRITC-labeled cells throughout the parenchyma, while
other areas within the same imaging ﬁeld have little to no detectable
TRITC-labeled cells (Fig. 2b). The distribution of TRITC+ cells is consis-
tent with the distribution pattern of transient vessel leaks observed in
Fig. 1. Serial imaging of the same CNS location also revealed that the ves-
sel leaks coincided with observed increase in the TRITC–dextran uptake
and activation of thenearbymicroglia, as judgedbymorphologic chang-
es (Fig. 2a, inset), thereby starting a cellular cascade that results in the
inﬁltration and accumulation of circulating immune cells.ical scores were achieved in mice pre-transferred with naïve 2D2 T cells (■; n = 6 from 2
EAE induction. (b)Dynamic TPM imaging of pial vessels (red) onday 3 after EAE induction.
n (b) over time revealed the transient and focal nature of the vessel leaks in ROIs 1 and 2.
the leaks in (d) was short. There were no ﬂares detected after day 3, up to 21 days. N= 4
12days of EAE induction. Arrows: PTx injections. N=19 from8 independent experiments.
injections. (h) ROI 5 (a cross-sectional viewof ROI 1 in (b)) revealed a slower clearance of
Scale bar = 25 μm. (i) The presence of vessel dyes (red) can be detected by IHC in the
erﬁcial vessels and the deep vessels away from the meningeal–parenchyma interface (*).
D.
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To assess how the phagocyte distribution may be affected by
neuroinﬂammatory stimuli, we compared the distribution and numbers
of TRITC+ cells following systemic exposure to PTx and the TLR4 ago-
nist, lipopolysaccharide (LPS). We observed a distinct distribution pat-
tern of parenchymal TRITC+ cells between the two stimuli: systemic
LPS produced an even distribution of TRITC+ cells throughout the entire
parenchyma andmeninges, whereas PTx treatment resulted in a patchy
TRITC+ distribution (data not shown) as seen with EAE induction
(Fig. 2b). Both PTx and LPS administration resulted in a signiﬁcant in-
crease in the appearance of TRITC+ cells in both the meninges (PTx,
df = 11, p = 0.0082; LPS, df = 8, p = 0.0004) and parenchyma (PTx,
df = 11, p = 0.046; LPS, df = 8, p = 0.0009) (Fig. 2c; two-tailed un-
paired t-test). This method allows serial documentation of the vessel
leak patterns in the same hosts with ﬁner time and space resolution
than previously reported (Findling et al., 1994).
CD11c+ DCs inﬁltrate the CNS following phagocyte activation
CD11c+DCs are required in EAE induction (Bailey et al., 2007;Miller
et al., 2007). To determine the time course of inﬁltrating DCs and their
phagocytic activities in the CNS, we imaged CD11c-GFP+ mice daily
during the ﬁrst 12 days of active EAE induction (Fig. 2d). We quantiﬁed
the number of CD11c-GFP+ cells, TRITC+ cells, or both in the meninges
and parenchyma (Fig. 2e; 1 way ANOVA with df = 41). We observed a
signiﬁcantly increased number of CD11c+TRITC− cells in the meninges
starting on days 3 through12,with increasing dextran uptake fromdays
9 to 12. The entry of CD11c+TRITC−DCs into the parenchymawasmuch
slower compared to those in themeninges,with DCs increasing in num-
ber starting on day 6. Their phagocytic capacity increases over the sub-
sequent 6 days. In contrast, the number of CD11c− TRITC+ cells in the
meninges decreased between days 3 to 12, even as parenchymal
CD11c− TRITC+ cell numbers remain constant throughout this period.
Presentation of myelin antigens by CNS APCs enhanced activated myelin-
speciﬁc T cell entry and retention
Following the characterization of CD11c+ and CD11c− APCs in the
EAE brain, we investigated the timing and antigen requirement of 2D2
cell recruitment and behavior within the CNS. More 2D2 cells began to
inﬁltrate the brain parenchyma on day 3 and signiﬁcantly more on
day 9 (Fig. 3a; n = 5 from 2 experiments, df = 8, p = 0.0082, 1 way
ANOVA). However, when mice adoptively transferred with naïve OTII
and 2D2 cells were immunized only with OVA323–339, we saw a near
complete absence of inﬁltrating 2D2 or OTII cells in the meninges or
the CNS parenchyma (Fig. 3b), even though both T cell populations
were found in equivalent numbers within the peripheral lymph nodes
(Fig. 3c). The few OTII cells resided only transiently in the CNS next to
blood vessels and migrated with a reduced speed as compared with
2D2 cells (Fig. 3d). The divergent behaviors between the two T cell pop-
ulations were observed in the presence of equivalent leaky CNS vessels,
phagocytic APC accumulation and robust T cell activation within the
samehost. Taken together, our data imply that the cooperation between
PTx-induced leaky vessels, resident and inﬁltratingAPCs, the availability
of CNS-derived antigens and activated myelin-speciﬁc T cells are pre-
conditions for MOG-speciﬁc T cell entry into the CNS, which in turn am-
pliﬁes other cellular inﬁltration later in the disease progression.Fig. 2. Focal vessel leaks induced localized activation of endogenous CNS immune cells and ac
conﬁned within CX3CR1+/GFP (green) cells. (b) TPM vessel imaging of the cortex on day 3 foll
imaged areas were devoid of pinocytic activities. The numbers indicate dextran-laden cell co
TRITC+ cells in the meninges and parenchyma following systemic exposure to LPS and PTx. *p
experiments. (d) Sequential CNS imaging of the CD11c-GFPmice over the ﬁrst 12 days of EAE in
CD11c+ (purple) cells in the left panel and TRITC+ only cells (red) in the right panel over time
TRITC+ (red) cells in the meninges and parenchyma over a 12-day sequential imaging exper
mean ± SD.Localized blood vessel leaks preceded phagocyte accumulation and the in-
ﬁltration of DCs and T cells
To further examine the cellular and structural cooperation leading to
EAE, we performedmultiplex sequential imaging to capture cellular in-
teractions among TRITC+ cells, DCs and 2D2 cells during the ﬁrst 9 days
of EAE induction. Following transient vessel leaks (Fig. 3e, day 4), the
vessel content was cleared with a concomitant increase in the number
of TRITC+ cells and the arrival of CD11c+ DCs by day 6 (Fig. 3e, days
6–9). This was followed on day 9 by a large number of inﬁltrating 2D2
cells that congregated near sites of previous vessel leaks (Fig. 3e, day
9), eventually leading to extensive inﬂammatory changes, with tail
and limb weakness beginning on days 10 onward (Fig. 1a). The 2D2
cells surveyed a large parenchymal area, while maintaining focal move-
ments surrounding sites of prior vessel leak where clusters of CD11c+
cells were also found (Fig. 3e, day 9 tracks; Movie 3). The 2D2 cells ex-
hibited both transient (b2 min) and prolonged (≥2 min) contacts with
DCs (Fig. 3f). Those 2D2 cells that interacted brieﬂy with CD11c+ DCs
migrated at faster velocities (~14.8± 4.2 μm/min), while those that ex-
hibited prolonged interactionwith DCs traveledwith reduced velocities
(~12.5±3.6 μm/min) (Fig. 3g). In all, 83% of 2D2 cells weremotile, with
6.1 ± 5.1% of 2D2 cells residing in the perivascular areas with limited
motility.
2D2 cells preferentially congregated in DC-rich regions
To assess whether 2D2 cells were preferentially drawn to sites of DC
aggregates, we analyzed the number of 2D2 cells entering a 50-μm radi-
us of a CD11c+-GFP+ cellular aggregate. Our analysis revealed a signif-
icant increase in the number of unique 2D2 cellsmoving toward an area
high in GFP signals as compared to areas with low GFP signals within
the same imaging ﬁeld (Fig. 3h; n = 5 from 2 experiments, df = 21,
p = 0.0069, two-tailed unpaired t-test). Contact duration analysis of
2D2 cells with CD11c+ and CD11c− phagocytes showed a trend toward
longer duration of contact with CD11c+ cells (Fig. 3i; n = 5 from 2 ex-
periments, df = 17, p value not signiﬁcant, 1 way ANOVA). We also
found a trend for a greater number of 2D2 cells egressing from nearby
blood vessels to enter the CD11c+ rich regions as compared to those en-
tering the vessels from the parenchyma (Fig. 3j; Movies 4, 5; n=5 from
2 experiments, df = 24, p value not signiﬁcant, two-tailed unpaired t-
test).
Histamine H1 receptor blockade reduced microglia activation, DC recruit-
ment, disease incidence and clinical severity
Histamine released bymast cells is implicated in PTx-mediated ves-
sel leak (Linthicum et al., 1982).We testedwhether blockade of the his-
tamine H1 receptor (H1R) could ameliorate observed vessel leak and
subsequent cellular accumulation events. We administered hydroxy-
zine (HXYZ), a H1R antagonist that readily crosses the BBB, in the drink-
ing water of mice undergoing EAE induction. We observed a 60%
reduction in EAE incidence among mice receiving HXYZ treatment
(Fig. 4a; n = 10 from 2 experiments). Despite HXYZ treatment via ga-
vage, however, we still observed PTx-induced vessel leaks (Figs. 4b, c;
Movie 6). Nevertheless, HXYZ treatment did result in a dramatic reduc-
tion in the number of TRITC+ parenchymal cells, with numbers compa-
rable to PBS control (Fig. 4d; PBS: PTx + HXYZ, df = 7, p value not
signiﬁcant, two-tailed unpaired t-test). These ﬁndings were furthercumulation of DCs. (a) Day 0 after EAE induction showed that all TRITC+ cells (red) were
owing PTx administration revealed aggregates of TRITC+ cells (red) while other similarly
unts within the boxed parenchymal volume. Scale bar = 100 μm. (c) Quantiﬁcation of
b 0.01, **p b 0.001, ***p b 0.0001. PBS, n = 7; PTx, n = 6; LPS, n = 4 from 2 independent
duction showed progressive changes in the accumulation of CD11c+ (green) and TRITC+/
. Scale bar = 60 μm. (e) Quantiﬁcation of CD11c+ (green), TRITC+/CD11c+ (purple) and
iment as shown in (d). N = 5 mice from 2 independent experiments. Data are shown as
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81D.S. Barkauskas et al. / Experimental Neurology 266 (2015) 74–85corroborated by TPM, showing a trend toward reduction of TRITC+ cells
and DCs as late as day 12 (Fig. 4e, day 3; df = 18, p = 0.0146; day 12
df = 22, p = 0.0386; two-tailed unpaired t-test). Flow cytometry anal-
ysis revealed a reduction in the number of both CD11b+CD11c+ DCs
(Fig. 4f; df = 7, p = 0.006, two-tailed unpaired t-test) and CD11b+-
CD11c− macrophages (Fig. 4g; df = 12, p = 0.0049, two-tailed un-
paired t-test), as well as a similar reduction in the number of
inﬁltrating CD8+ (Fig. 5a; df = 8, p = 0.0013, two-tailed unpaired t-
test) and CD4+ T cells (Fig. 5b; df = 8, p= 0.0005, two-tailed unpaired
t-test) in HXYZ-treated groups early on day 3. This was accompanied by
a reduced number of CNS inﬁltrating IL-17 and IFN-γ producing CD4+ T
cells (Fig. 5c, day 9; IL-17: df = 8, p = 0.036; IFN-γ: df = 8, p = 0.024;
two-tailed unpaired t-test), even though the spleens of these mice
contained similar numbers of IL-17 and IFN-γ producing CD4+ T cells
(Fig. 5d).
Discussion
CNS vessel leak has been implicated as a trigger in neurodegenera-
tive disorders including epilepsy, Alzheimer, and Parkinson's disease
(Hawkins and Davis, 2005; Zlokovic, 2011). Although changes in CNS
vessel permeability have been documented in vivo, the timing and ki-
netics at the level of detail as described in the current study has not
been reported previously (Davalos et al., 2012; Findling et al., 1994;
Kenne and Lindbom, 2011; McGavern and Kang, 2011). We provided
evidence of the transient and focal nature of altered vascular permeabil-
ity in early EAE induction as an initiating event, not a byproduct of effec-
tor T cell aggregation and tissue destruction near the perivascular
pathologic lesions. These leaks occurred during PTx treatment, where
blood contents including plasma proteins and ﬁbrinogen (Davalos
et al., 2012) are released into the parenchyma and initiate a parenchy-
mal inﬂammatory response including the activation of the phagocytic
capacity of resident CX3CR1+ microglia (Neumann et al., 2009), well
in advance of any observable clinical symptoms. Vessel leaks were
found in the meninges and throughout the parenchyma. During the
early vessel leaks following PTx administration,we did not detect inﬂux
of circulating monocytes or T cells in the cortex, suggesting that the
opening of the BBB at this stage does not permit a large inﬂux of circu-
lating cells into the imaged region of the brain. At later time points (days
4–6) when the vessel leakage subsides, we began to observe increasing
immune cell inﬁltrate coincident with a second wave of vessel leak
(Figs. 1d, e; days 7–9), an observation consistent with the two-step par-
adigm of EAE induction (Sallusto et al., 2012). Interestingly, while PTx
administration resulted in focal dextran-uptake activity, systemic ad-
ministration of LPS, the classical TLR4 agonist, resulted in a diffuse pat-
tern of dextran uptake in the CNS presumably due to the direct effect
of LPS on endothelial and immune cells throughout the body
(Andonegui et al., 2003, 2009). The observed differential effects be-
tween PTx and LPS on CNS dextran uptake are interesting, since PTx
has been shown to evoke intracellular signaling through TLR4 (Kerfoot
et al., 2004).
Mice with functionally deﬁcient microglia exhibited delayed EAE
onset and reduced severity, suggesting microglia contribution in EAE
pathogenesis (Greter et al., 2005; Heppner et al., 2005). Peritonealmac-
rophages activated with ConA display increased pinocytosisFig. 3. Peripherally activated T cells accumulated andmigrated near sites of vessel leak and DC a
2D2 co-transferredmice that were immunized with both OVA323–339 andMOG35–55 peptide
vation of naïve OTII and 2D2 co-transferredmice that were immunizedwith only the OVA323–
(Vβ11) cells in the peripheral draining lymph nodes of mice in (a). (d) Comparison of the avera
early in EAE induction (day 4) resulted in TRITC+ (red) and CD11c-GFP+ (green) cell accumula
Colored tracks on day 9 highlight the paths taken by individual 2D2 cells (blue) near areas of
(f) Contact duration of CD11c-GFP+ cells by 2D2 T cells on day 9. (g) Average velocity of 2D2
CD11c+ rich regions (GFPhi) versus low CD11c-GFP (GFPlo) regions on days 9 and 12. N = 5 f
APCs on days 9 and 12. N = 5 from 2 independent experiments. (j) More 2D2 cells egressed f
vessels from the CNS on days 9 and 12. N = 5 from 2 independent experiments. **p b 0.001; nconcomitant with an increase in phagocytosis, and prolonged pinocyto-
sismay be an indicator ofmacrophage activation (Cohn, 1966). Depend-
ing on the mode of activation, however, pinocytosis may also decrease
as compared to non-activated macrophages (Montaner et al., 1999;
Tsang et al., 2000). Pinocytosis is a highly metabolic process and re-
quires an ATP source such as dextran (Edelson et al., 1975). In our
study,we found that themicroglia surrounding the vessel leakswere pi-
nocytic. Using the CX3CR1+/GFP reportermouse,we showed that themi-
croglia andmacrophages constitute themain pinocytic populations that
absorb vessel contents in the ﬁrst 3 days. These cells can internalize ves-
sel contents in response to TLR agonist stimulation by one of two ways.
First, they act as scavengers, removing blood solutes following vessel
leaks. Second, perivascular CX3CR1+ cells can sample blood contents di-
rectly within intact blood vessels through intravascular processes
(Barkauskas et al., 2013).
Bone marrow derived myeloid cells are also important in regulating
CNS inﬂammatory response, where inﬁltrating DCs with functional
MHCII are required for EAE induction (Bailey et al., 2007; Greter et al.,
2005; Heppner et al., 2005; Juedes and Ruddle, 2001; Miller et al.,
2007; Pashenkov et al., 2003; Seraﬁni et al., 2000). Activated OTII cells
can access the CNS only in the presence of co-activated 2D2 cells. In con-
trast, activated OTII cells in the presence of naïve 2D2 cells were incapa-
ble of doing so, despite the presence of pinocytic microglia and DCs.
These results suggest that T cells do not simply enter CNS passively
through disrupted BBB but require activated 2D2 cells recognizing
myelin-presenting APCs. Our data support the view that APCs present-
ing endogenous CNS peptides are critical to license T cell recruitment
and retention in the EAE brain. Our TPM imaging and FACS data are in
good agreementwith reports showing that 5–10% of CD11b+ cells pres-
ent myelin basic protein as early as day 1 after EAE induction, whereas
CD11c+ DCs are not detected till after day 5 and only present myelin
basic protein from day 7 onwards (Sosa et al., 2013).
T cell inﬁltration into the brainwas thought to only occur at the cho-
roid plexus, although recent data suggest an alternate route via VRS and
the pial vessels in the SAS (Goverman, 2009; Ransohoff and Engelhardt,
2012). Our imaging data captured T cells migrating directly into the pa-
renchyma from VRS, and migrated near CD11c+ DCs in a pattern that
were in contrast to published data showing non-directed T cell behavior
during the peak of EAE disease (Bartholomaus et al., 2009; Herz et al.,
2011; McGavern and Kang, 2011; Mues et al., 2013; Siffrin et al.,
2010). Our ﬁnding of the focal T cell accumulation and their repeated
surveillance with DCs during the asymptomatic phase of EAE suggests
direct communication between newly arrived 2D2 and DCs. These
short contacts were similar to other reports, which utilized calcium
ﬂux and NFAT reporter mice to show that inﬁltrating T cells in the
spine of passively induced EAE mice were in an activated state while
meandering and making short contacts with phagocytic APCs
(Lodygin et al., 2013; Mues et al., 2013). Here, we showed that 2D2
cells are re-activated by DCs in the cortex before these T cells exert
their pathogenic effector function, eventually leading to the develop-
ment of clinical symptoms.
PTx has been shown to increase the permeability of vessels
(Linthicum et al., 1982; Locht et al., 2011; Miyata and Morita, 2011)
with direct effects on the choroid plexus and cerebral endothelial cells
(Brückener et al., 2003; Lapilla et al., 2011). In the brain, PTx isggregation in an antigen-dependentmanner. (a) Direct TPMobservation of naïve OTII and
s in the presence of CFA and PTx. N= 5 from 2 independent experiments. (b) TPM obser-
339 peptide. N= 3 from 1 experiment. (c) Flow cytometry analysis of OTII (Vα2) and 2D2
gemigration speeds of OTII and 2D2 cells found in the brain. (e) Sites of focal vessel leaks
tion (days 6–9), along with localized 2D2 cell (blue) migration and accumulation (day 9).
CD11c-GFP+ cell clusters (green) in the parenchyma (P) compared to the meninges (M).
cells based on interaction times. (h) Total number of unique 2D2 cells migrating toward
rom 2 independent experiments. (i) 2D2 cells exhibited similar overall contact time with
rom the blood vessels into the parenchyma as compared to those entering into the blood
.s., not signiﬁcant. Data are shown as mean ± SD.
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Fig. 5. Effects of HXYZ on T cell numbers during EAE induction. HXYZwas administered via gavage from day−1 to day 12 while EAEwas being induced.Whole-brain Percoll isolations of
individual cells fromHXYZ-treated and control micewere performed. Flow cytometry analysis of the isolated cells showed the following: (a) a signiﬁcant decrease in the number of CD8+
cells in the CNS with HXYZ treatment on day 3. N= 8 from 3 independent experiments. (b) A signiﬁcant decrease in the number of CD4+ cells in the CNS with HXYZ treatment on day 3.
N = 8 from 3 independent experiments. (c) Although the total number of CD4+ cells in the CNS was similar between treatment and control groups (b) on day 9, there was a signiﬁcant
decrease in the number of IFN-γ and IL-17 producing cells within the CNS. N=5 from 2 independent experiments. (d) The total number of CD4+ T cells expressing IFN-γ, IL-17 and FoxP3
was not signiﬁcantly different with HXYZ treatment on day 9 in the spleen. N = 5 from 2 independent experiments. *p b 0.01; **p b 0.001; ***p b 0.0001; n.s., not signiﬁcant.
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adhesion molecule expression, and alters endothelial tight junctions
and astrocyte end feet barrier integrity. Mice deﬁcient in histamine re-
ceptors 1 and 2 have reduced EAE severity and BBB permeability
(Saligrama et al., 2012). The CSF of MS patients contains elevated levels
of histamine, and H1R antagonists have shown clinical beneﬁts in MS
(Jadidi-Niaragh and Mirshaﬁey, 2010). In a clinical trial, hydroxyzine
was shown to stabilize or improve symptoms in 75% of MS patients
(Logothetis et al., 2005).
Interestingly, we only observed a trend toward diminished frequen-
cy, but not a complete absence of vessel leakage when HXYZ was ad-
ministered. Our observation suggests that mechanism(s) other than
histamine are responsible for vessel permeability changes under
neuroinﬂammatory conditions, such as tachykinins (e.g. substance P),
serotonin, and bradykinin (Annunziata et al., 1998, 2002; Feng et al.,
1996; Kakizoe et al., 1997; Olesen, 1985; Reinke et al., 2006; Saria
et al., 1983). Regardless, we showed that HXYZ treatment reduced
EAE disease incidence or severity in 60% of the mice. Furthermore,
HXYZ initially reduced the extent of dextran uptake by meningeal
macrophage as documented by TPM and decreased the myeloid-Fig. 4.Histamine receptor blockade inhibited early activation of CNS TRITC+ cells, diminishedD
reduced severity of disease when exposed to hydroxyzine (HXYZ) via drinking water during E
overall clinical severity. N = 10 per group from 2 independent experiments. (b) Frequency o
to mice via gavage followed by EAE induction. No statistical differences in vessel leaks were ob
per group from 2 independent experiments. (c) EAE-inducedmice treatedwith HXYZ showed a
and parenchymawith PTx treatment versus PTx+HXYZ treated as compared to PBS controls. P
TPM imaging data analysis of HXYZ-treated and control mice showed a substantial decrease in
between days 3 and 12. HXYZ-treated, n = 6; control, n = 5 from 2 independent experiments
cytometry analysis revealed a signiﬁcant decrease in the number of CD11b+CD11c+ cells in th
pendent experiments. (g) The number of CD11b+CD11c− cells in the CNS of HXYZ-treatedmice
from 2 independent experiments. Data are shown as mean ± SD. *p b 0.01; **p b 0.001; ***p bderived APC inﬁltration globally in the CNS. Importantly, preventing
the early activation of the microglia with HXYZ resulted in a reduc-
tion of both non-speciﬁc T cell inﬁltration on day 3 and antigen-
speciﬁc T cell inﬁltration on day 12. These data provide further evi-
dence supporting the view that the microglia play critical roles in
early EAE induction, and that blocking microglia activation during
the inﬂammatory phase can lessen myelin and neuronal destruction
(Giunti et al., 2013; Juedes and Ruddle, 2001; Saijo and Glass, 2011).
Future work remains to fully understand the regulation of focal and
intermittent CNS vessel disruption that was only partially blocked
by H1R blockade.
The exact kinetics of cellular inﬂammation in the brain have been
hard to study, especially during the very early stages of EAE induction
prior to disease manifestation, due to the low number of relevant cells
detected using conventional bulk cellular assays. Our present study
helps to shed new light on the precise, local and sequential interplay
among CNS tissues and cellular factors that coordinately manifest in
early EAE pathophysiology involving early intermittent BBB disruption,
local activation of themicroglia, subsequent recruitment of DCs, and the
surveillance behavior of pathogenic CD4+ T cells in the EAE brain.C and 2D2 cell accumulation, and blunted EAE severity. (a) 60% ofmice displayed absent or
AE induction, with 20% disease-free incidence and 40% with a delayed onset and reduced
f CNS vessel leaks was observed by direct TPM observation after HXYZ was administered
served in HXYZ-gavaged mice as compared to control mice during EAE induction. N = 6
dramatic reduction in TRITC+ cells. Scale bar= 50 μm. (d) Cell number in bothmeninges
BS, n= 7; PTx, n=6; PTx+HXYZ, n= 4 from 2 independent experiments. (e) Sequential
parenchymal and meningeal CD11c+ and CD11c− TRITC+ numbers during EAE induction
. (f) After whole brain Percoll isolation of cells from HXYZ-treated and control mice, ﬂow
e CNS of HXYZ-treated mice on days 3 and 6 following EAE induction. N = 8 from 2 inde-
was also signiﬁcantly lower as compared to control on day 6 following EAE induction. N=8
0.0001; n.s., not signiﬁcant.
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